IMGN - ImmunoGen - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IMGN is currently covered by 9 analysts with an average price target of $34.08. This is a potential upside of $2.85 (9.13%) from yesterday's end of day stock price of $31.23.

ImmunoGen's activity chart (see below) currently has 75 price targets and 97 ratings on display. The stock rating distribution of IMGN is 69.23% BUY and 30.77% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 92.72% with an average time for these price targets to be met of 539.22 days.

Highest price target for IMGN is $29, Lowest price target is $4, average price target is $34.08.

Most recent stock forecast was given by PETER LAWSON from BARCLAYS on 01-Dec-2023. First documented stock forecast 06-Aug-2012.

Currently out of the existing stock ratings of IMGN, 18 are a BUY (69.23%), 8 are a HOLD (30.77%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$27

1 years 17 days ago
(01-Dec-2023)

4/4 (100%)

$9.83 (57.25%)

134

Hold

$31

$-0.23 (-0.74%)

$26

1 years 17 days ago
(01-Dec-2023)

4/4 (100%)

$1.68 (5.73%)

224

Hold

$31

$-0.23 (-0.74%)

$12

1 years 17 days ago
(01-Dec-2023)

2/2 (100%)

$1.68 (5.73%)

293

Hold

$24

$-7.23 (-23.15%)

$6

1 years 17 days ago
(01-Dec-2023)

5/6 (83.33%)

$-5.32 (-18.14%)

721

Hold

$25

$-6.23 (-19.95%)

1 years 17 days ago
(01-Dec-2023)

4/5 (80%)

$-4.32 (-14.73%)

1442

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is IMGN (ImmunoGen) average time for price targets to be met?

On average it took 539.22 days on average for the stock forecasts to be realized with a an average price target met ratio 92.72

Which analyst has the current highest performing score on IMGN (ImmunoGen) with a proven track record?

SWAYAMPAKULA RAMAKANTH

Which analyst has the most public recommendations on IMGN (ImmunoGen)?

Swayampakula Ramakanth has 5 price targets and 9 ratings on IMGN

Which analyst is the currently most bullish on IMGN (ImmunoGen)?

Christopher Marai with highest potential upside - $8.13

Which analyst is the currently most reserved on IMGN (ImmunoGen)?

Matthew Harrison with lowest potential downside - -$29.93

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?